{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:04:32Z","timestamp":1791072272461,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1093\/ije\/30.6.1309","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:28:32Z","timestamp":1027708112000},"page":"1309-1313","source":"Crossref","is-referenced-by-count":70,"title":["Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis"],"prefix":"10.1093","volume":"30","author":[{"given":"L","family":"Gras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RE","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AE","family":"Ades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DT","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12]]},"reference":[{"key":"key\n\t\t\t\t20170712064021_R1","doi-asserted-by":"crossref","unstructured":"Jeannel D, Costagliola D, Niel G, Hubert B, Danis M. What is known about the prevention of congenital toxoplasmosis? Lancet1990;336:359\u201361.","DOI":"10.1016\/0140-6736(90)91890-M"},{"key":"key\n\t\t\t\t20170712064021_R2","unstructured":"Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein J (eds). Infectious Diseases of the Fetus and Newborn. 4th Edn. Pennsylvania: WB Saunders, 1995, pp.140\u2013267."},{"key":"key\n\t\t\t\t20170712064021_R3","doi-asserted-by":"crossref","unstructured":"Guerina NG, Hsu HW, Meissner HC et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med1994;330:1858\u201363.","DOI":"10.1056\/NEJM199406303302604"},{"key":"key\n\t\t\t\t20170712064021_R4","doi-asserted-by":"crossref","unstructured":"Lebech M, Andersen O, Christensen NC et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet1999;353:1834\u201337.","DOI":"10.1016\/S0140-6736(98)11281-3"},{"key":"key\n\t\t\t\t20170712064021_R5","unstructured":"Conyn-van-Spaedonck MAE. Prevention of Congenital Toxoplasmosis in the Netherlands (Thesis). National Institute of Public Health and Environmental Protection (Netherlands), ISBN 90\u20139004179\u20136. 1991."},{"key":"key\n\t\t\t\t20170712064021_R6","doi-asserted-by":"crossref","unstructured":"Koppe JG, Loewer Sieger DH, de Roever Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet1986;i:254\u201356.","DOI":"10.1016\/S0140-6736(86)90785-3"},{"key":"key\n\t\t\t\t20170712064021_R7","doi-asserted-by":"crossref","unstructured":"Berrebi A, Kobuch WE, Bessieres MH et al. Termination of pregnancy for maternal toxoplasmosis. Lancet1994;344:36\u201339.","DOI":"10.1016\/S0140-6736(94)91054-5"},{"key":"key\n\t\t\t\t20170712064021_R8","doi-asserted-by":"crossref","unstructured":"Foulon W, Villena I, Stray-Pedersen, B et al. Treatment of toxoplasmosis during pregnancy: a multicentre study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol1999;180:410\u201315.","DOI":"10.1016\/S0002-9378(99)70224-3"},{"key":"key\n\t\t\t\t20170712064021_R9","doi-asserted-by":"crossref","unstructured":"Couvreur J, Thulliez P, Daffos F et al. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagn Ther1993;8:45\u201350.","DOI":"10.1159\/000263746"},{"key":"key\n\t\t\t\t20170712064021_R10","doi-asserted-by":"crossref","unstructured":"Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet1999;353:1829\u201333.","DOI":"10.1016\/S0140-6736(98)08220-8"},{"key":"key\n\t\t\t\t20170712064021_R11","doi-asserted-by":"crossref","unstructured":"Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn, D. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: a cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol2001;30:1303\u201308.","DOI":"10.1093\/ije\/30.6.1303"},{"key":"key\n\t\t\t\t20170712064021_R12","doi-asserted-by":"crossref","unstructured":"Derouin F. Drugs effective against Toxoplasma gondii. Present status and future perspective. In: Amboise-Thomas P, Petersen E (eds). Congenital Toxoplasmosis. Scientific Background, Clinical Management and Control. Paris: Springer Verlag, 2000, pp.95\u2013110.","DOI":"10.1007\/978-2-8178-0847-5_7"},{"key":"key\n\t\t\t\t20170712064021_R13","doi-asserted-by":"crossref","unstructured":"McLeod R, Dowel M. Basic immunology: fetus and the newborn. In: Amboise-Thomas P, Petersen E (eds). Congenital Toxoplasmosis. Scientific Background, Clinical Management and Control. Paris: Springer Verlag, 2000, pp.37\u201368.","DOI":"10.1007\/978-2-8178-0847-5_4"},{"key":"key\n\t\t\t\t20170712064021_R14","doi-asserted-by":"crossref","unstructured":"Alexander J, Roberts CW, Walker W, Reichmann G, Hunter CA. The immunology of Toxoplasma gondii infection in the immune-competent host. In: Amboise-Thomas P, Petersen E (eds). Congenital Toxoplasmosis. Scientific Background, Clinical Management and Control. Paris: Springer Verlag, 2000, pp.69\u201382.","DOI":"10.1007\/978-2-8178-0847-5_5"},{"key":"key\n\t\t\t\t20170712064021_R15","doi-asserted-by":"crossref","unstructured":"Dammann O, Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol1998;5:190\u2013201.","DOI":"10.1016\/S1071-9091(98)80034-X"},{"key":"key\n\t\t\t\t20170712064021_R16","doi-asserted-by":"crossref","unstructured":"Luder CGK, Giraldo Velasquez MA, Sendtner M, Gross U. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol1999;93:23\u201332.","DOI":"10.1006\/expr.1999.4421"},{"key":"key\n\t\t\t\t20170712064021_R17","doi-asserted-by":"crossref","unstructured":"Roberts F, McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today1999;15:51\u201357.","DOI":"10.1016\/S0169-4758(98)01377-5"},{"key":"key\n\t\t\t\t20170712064021_R18","doi-asserted-by":"crossref","unstructured":"Brezin AP, Kasner L, Thulliez P et al. Ocular toxoplasmosis in the fetus. immunohistochemistry analysis and DNA amplification. Retina1994; 14:19\u201326.","DOI":"10.1097\/00006982-199401000-00005"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/30\/6\/1309\/18524807\/301309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T05:51:02Z","timestamp":1503467462000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/30.6.1309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,12]]},"published-print":{"date-parts":[[2001,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/30.6.1309","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}